Singleron Biotechnologies

Founded in 2017 and headquartered in Göttingen, Germany, Singleron Biotechnologies is a key player in the rapidly growing single-cell analysis market. The company offers a vertically integrated suite of products and services covering the entire workflow from tissue preservation and dissociation to single-cell processing, library preparation, sequencing, and bioinformatic analysis. With a global workforce and a track record supporting numerous publications, Singleron serves academic, clinical, and pharmaceutical customers worldwide. Its business model combines the sale of platform instruments and consumables with high-value sequencing and data analysis services.

Proprietary end-to-end single-cell multi-omics platform encompassing microfluidic SCOPE-chip and bead-based single-cell partitioning, automated tissue dissociation (PythoN systems), high-throughput library preparation (Tensor system), a comprehensive suite of reagent kits for various applications (scRNA-seq, snRNA-seq, immune profiling, ATAC-seq), and integrated bioinformatics software for data analysis.

Singleron competes in the crowded single-cell analysis market against the clear leader, 10x Genomics, as well as other established players like BD Biosciences, Parse Biosciences, and Scale Biosciences. Its differentiation lies in its broad, vertically integrated portfolio (instruments, kits, software, services) and specific focus on challenging sample types like FFPE. Competition is based on technology performance, ease of use, workflow integration, price, and the strength of customer support.